-
Je něco špatně v tomto záznamu ?
Laparoscopic myomectomy after or without pre-treatment with ulipristal acetate
M. Mara, B. Boudova, Z. Lisa, M. Andrasova, P. Dundr, D. Kuzel
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 2008-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2001-01-01 do Před 1 rokem
- MeSH
- laparoskopie * MeSH
- lidé MeSH
- myomektomie * MeSH
- nádory dělohy * farmakoterapie chirurgie MeSH
- norpregnadieny * MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: The aim was to compare the surgical experience and the clinical results of laparoscopic myomectomy (LM) with or without pre-treatment with ulipristal acetate (UPA). MATERIAL AND METHODS: Fifty-four women who underwent LM for intramural myomas and were pre-treated with three months of UPA were matched with 54 patients with the same procedure but no hormonal pre-treatment. All operations were performed by one team. The technical features of the procedures were reviewed and evaluated by two other laparoscopists, unaware of the eventual use of UPA. The clinical, histological, and reproductive outcomes of each patient were assessed and the results of both groups were compared. RESULTS: The groups did not significantly differ in operation time, intra-operative blood loss, drop in hemoglobin concentration, number of complications, pregnancy rate, and delivery rate. Women pre-treated with UPA had significantly longer hospital stays, higher numbers of histologically abnormal leiomyomas, and higher rates of fibroids peri-procedurally assessed as soft and disintegrating. The other four technical parameters of LM were comparable in both groups. CONCLUSIONS: The surgeons performing LM in women pre-treated with UPA should be aware of the abnormal texture of enucleated myomas. Nevertheless, this does not negatively affect the other surgical and clinical outcomes of these patients.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011545
- 003
- CZ-PrNML
- 005
- 20210507103606.0
- 007
- ta
- 008
- 210420s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/13645706.2019.1674337 $2 doi
- 035 __
- $a (PubMed)31617772
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Mara, Michal $u Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Republic of Czech
- 245 10
- $a Laparoscopic myomectomy after or without pre-treatment with ulipristal acetate / $c M. Mara, B. Boudova, Z. Lisa, M. Andrasova, P. Dundr, D. Kuzel
- 520 9_
- $a INTRODUCTION: The aim was to compare the surgical experience and the clinical results of laparoscopic myomectomy (LM) with or without pre-treatment with ulipristal acetate (UPA). MATERIAL AND METHODS: Fifty-four women who underwent LM for intramural myomas and were pre-treated with three months of UPA were matched with 54 patients with the same procedure but no hormonal pre-treatment. All operations were performed by one team. The technical features of the procedures were reviewed and evaluated by two other laparoscopists, unaware of the eventual use of UPA. The clinical, histological, and reproductive outcomes of each patient were assessed and the results of both groups were compared. RESULTS: The groups did not significantly differ in operation time, intra-operative blood loss, drop in hemoglobin concentration, number of complications, pregnancy rate, and delivery rate. Women pre-treated with UPA had significantly longer hospital stays, higher numbers of histologically abnormal leiomyomas, and higher rates of fibroids peri-procedurally assessed as soft and disintegrating. The other four technical parameters of LM were comparable in both groups. CONCLUSIONS: The surgeons performing LM in women pre-treated with UPA should be aware of the abnormal texture of enucleated myomas. Nevertheless, this does not negatively affect the other surgical and clinical outcomes of these patients.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a laparoskopie $7 D010535
- 650 12
- $a norpregnadieny $7 D009649
- 650 _2
- $a těhotenství $7 D011247
- 650 12
- $a myomektomie $7 D063186
- 650 12
- $a nádory dělohy $x farmakoterapie $x chirurgie $7 D014594
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Boudova, Barbora $u Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Republic of Czech
- 700 1_
- $a Lisa, Zdenka $u Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Republic of Czech
- 700 1_
- $a Andrasova, Martina $u Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Republic of Czech
- 700 1_
- $a Dundr, Pavel $u Department of Pathology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a Kuzel, David $u Department of Obstetrics and Gynecology, General Faculty Hospital and 1st Medical Faculty, Charles University, Prague, Republic of Czech
- 773 0_
- $w MED00003375 $t Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy $x 1365-2931 $g Roč. 30, č. 1 (2021), s. 55-62
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31617772 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103605 $b ABA008
- 999 __
- $a ok $b bmc $g 1650046 $s 1131924
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 30 $c 1 $d 55-62 $e 20191016 $i 1365-2931 $m Minimally invasive therapy & allied technologies $n Minim Invasive Ther Allied Technol $x MED00003375
- LZP __
- $a Pubmed-20210420